Seiferling 2016 EMBO Rep: Difference between revisions

From Bioblast
(Created page with "{{Publication |title=Seiferling D, Szczepanowska K, Becker C, Senft K, Hermans S, Maiti P, KΓΆnig T, Kukat A, Trifunovic A (2016) Loss of CLPP alleviates mitochondrial cardiomyop...")
Β 
No edit summary
Line 1: Line 1:
{{Publication
{{Publication
|title=Seiferling D, Szczepanowska K, Becker C, Senft K, Hermans S, Maiti P, KΓΆnig T, Kukat A, Trifunovic A (2016) Loss of CLPP alleviates mitochondrial cardiomyopathy without affecting the mammalian UPRmt. EMBO Rep 17:953-64. Β 
|title=Seiferling D, Szczepanowska K, Becker C, Senft K, Hermans S, Maiti P, KΓΆnig T, Kukat A, Trifunovic A (2016) Loss of CLPP alleviates mitochondrial cardiomyopathy without affecting the mammalian UPRmt. EMBO Rep 17:953-64.
|info=[http://www.ncbi.nlm.nih.gov/pubmed/27154400 PMID: 27154400]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/27154400 PMID: 27154400]
|authors=Seiferling D, Szczepanowska K, Becker C, Senft K, Hermans S, Maiti P, Koenig T, Kukat A, Trifunovic A
|authors=Seiferling D, Szczepanowska K, Becker C, Senft K, Hermans S, Maiti P, Koenig T, Kukat A, Trifunovic A
Line 16: Line 16:
|tissues=Heart
|tissues=Heart
|preparations=Isolated mitochondria
|preparations=Isolated mitochondria
|enzymes=Complex I, Complex II;succinate dehydrogenase, Complex III, Complex V;ATP synthase
|diseases=Cardiovascular
|couplingstates=LEAK, OXPHOS, ETS
|couplingstates=LEAK, OXPHOS, ETS
|substratestates=CI, CI&II
|substratestates=CI, CI&II
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=Labels, 2016-07
|additional=2016-07
}}
}}

Revision as of 13:39, 14 July 2016

Publications in the MiPMap
Seiferling D, Szczepanowska K, Becker C, Senft K, Hermans S, Maiti P, KΓΆnig T, Kukat A, Trifunovic A (2016) Loss of CLPP alleviates mitochondrial cardiomyopathy without affecting the mammalian UPRmt. EMBO Rep 17:953-64.

Β» PMID: 27154400

Seiferling D, Szczepanowska K, Becker C, Senft K, Hermans S, Maiti P, Koenig T, Kukat A, Trifunovic A (2016) EMBO Rep

Abstract: The mitochondrial matrix protease CLPP plays a central role in the activation of the mitochondrial unfolded protein response (UPR(mt)) in Caenorhabditis elegans. Far less is known about mammalian UPR(mt) signaling, although similar roles were assumed for central players, including CLPP. To better understand the mammalian UPR(mt) signaling, we deleted CLPP in hearts of DARS2-deficient animals that show robust induction of UPR(mt) due to strong dysregulation of mitochondrial translation. Remarkably, our results clearly show that mammalian CLPP is neither required for, nor it regulates the UPR(mt) in mammals. Surprisingly, we demonstrate that a strong mitochondrial cardiomyopathy and diminished respiration due to DARS2 deficiency can be alleviated by the loss of CLPP, leading to an increased de novo synthesis of individual OXPHOS subunits. These results question our current understanding of the UPR(mt) signaling in mammals, while introducing CLPP as a possible novel target for therapeutic intervention in mitochondrial diseases.

Β© 2016 The Authors. β€’ Keywords: CLPP, DARS2, Cardiomyopathy, Mitochondrial translation, Mitochondrial unfolded protein response

β€’ O2k-Network Lab: DE Cologne Trifunovic A


Labels: MiParea: Respiration, nDNA;cell genetics  Pathology: Cardiovascular 

Organism: Mouse  Tissue;cell: Heart  Preparation: Isolated mitochondria  Enzyme: Complex I, Complex II;succinate dehydrogenase, Complex III, Complex V;ATP synthase 

Coupling state: LEAK, OXPHOS, ETS"ETS" is not in the list (LEAK, ROUTINE, OXPHOS, ET) of allowed values for the "Coupling states" property. 

HRR: Oxygraph-2k 

2016-07 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.